305 related articles for article (PubMed ID: 20629189)
1. PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Iden DL; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2010 Nov; 58(14):1727-38. PubMed ID: 20629189
[TBL] [Abstract][Full Text] [Related]
2. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
[TBL] [Abstract][Full Text] [Related]
3. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
McLaughlin M; Barrie JA; Karim S; Montague P; Edgar JM; Kirkham D; Thomson CE; Griffiths IR
Glia; 2006 May; 53(7):715-22. PubMed ID: 16506223
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a PLP-overexpressing transgenic rat, a model for the connatal form of Pelizaeus-Merzbacher disease.
Mayer JA; Larsen EC; Kondo Y; Duncan ID
Neurobiol Dis; 2011 Nov; 44(2):231-8. PubMed ID: 21784154
[TBL] [Abstract][Full Text] [Related]
5. Distinct phenotypes associated with increasing dosage of the PLP gene: implications for CMT1A due to PMP22 gene duplication.
Anderson TJ; Klugmann M; Thomson CE; Schneider A; Readhead C; Nave KA; Griffiths IR
Ann N Y Acad Sci; 1999 Sep; 883():234-46. PubMed ID: 10586248
[TBL] [Abstract][Full Text] [Related]
6. The PLP mutants from mouse to man.
Duncan ID
J Neurol Sci; 2005 Feb; 228(2):204-5. PubMed ID: 15694207
[No Abstract] [Full Text] [Related]
7. Genetic background determines phenotypic severity of the Plp rumpshaker mutation.
Al-Saktawi K; McLaughlin M; Klugmann M; Schneider A; Barrie JA; McCulloch MC; Montague P; Kirkham D; Nave KA; Griffiths IR
J Neurosci Res; 2003 Apr; 72(1):12-24. PubMed ID: 12645075
[TBL] [Abstract][Full Text] [Related]
8. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
[TBL] [Abstract][Full Text] [Related]
9. PLP1 gene duplication causes overexpression and alteration of the PLP/DM20 splicing balance in fibroblasts from Pelizaeus-Merzbacher disease patients.
Regis S; Grossi S; Corsolini F; Biancheri R; Filocamo M
Biochim Biophys Acta; 2009 Jun; 1792(6):548-54. PubMed ID: 19376225
[TBL] [Abstract][Full Text] [Related]
10. Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligodendroglia: implications for dysmyelination in spastic paraplegia.
Krämer-Albers EM; Gehrig-Burger K; Thiele C; Trotter J; Nave KA
J Neurosci; 2006 Nov; 26(45):11743-52. PubMed ID: 17093095
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of DM20 messenger RNA in two brothers with Pelizaeus-Merzbacher disease.
Carango P; Funanage VL; Quirós RE; Debruyn CS; Marks HG
Ann Neurol; 1995 Oct; 38(4):610-7. PubMed ID: 7574457
[TBL] [Abstract][Full Text] [Related]
12. Evidence for possible interactions between PLP and DM20 within the myelin sheath.
McLaughlin M; Hunter DJ; Thomson CE; Yool D; Kirkham D; Freer AA; Griffiths IR
Glia; 2002 Jul; 39(1):31-6. PubMed ID: 12112373
[TBL] [Abstract][Full Text] [Related]
13. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
Woodward KJ
Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
[TBL] [Abstract][Full Text] [Related]
14. Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease.
Wolf NI; Sistermans EA; Cundall M; Hobson GM; Davis-Williams AP; Palmer R; Stubbs P; Davies S; Endziniene M; Wu Y; Chong WK; Malcolm S; Surtees R; Garbern JY; Woodward KJ
Brain; 2005 Apr; 128(Pt 4):743-51. PubMed ID: 15689360
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease.
Cailloux F; Gauthier-Barichard F; Mimault C; Isabelle V; Courtois V; Giraud G; Dastugue B; Boespflug-Tanguy O
Eur J Hum Genet; 2000 Nov; 8(11):837-45. PubMed ID: 11093273
[TBL] [Abstract][Full Text] [Related]
16. Proteolipid protein dimerization at cysteine 108: Implications for protein structure.
Daffu G; Sohi J; Kamholz J
Neurosci Res; 2012 Oct; 74(2):144-55. PubMed ID: 22902553
[TBL] [Abstract][Full Text] [Related]
17. Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease.
Koizume S; Takizawa S; Fujita K; Aida N; Yamashita S; Miyagi Y; Osaka H
Neuroscience; 2006 Sep; 141(4):1861-9. PubMed ID: 16844304
[TBL] [Abstract][Full Text] [Related]
18. Current concepts of PLP and its role in the nervous system.
Griffiths I; Klugmann M; Anderson T; Thomson C; Vouyiouklis D; Nave KA
Microsc Res Tech; 1998 Jun; 41(5):344-58. PubMed ID: 9672418
[TBL] [Abstract][Full Text] [Related]
19. Trafficking of PLP/DM20 and cAMP signaling in immortalized jimpy oligodendrocytes.
Ghandour MS; Feutz AC; Jalabi W; Taleb O; Bessert D; Cypher M; Carlock L; Skoff RP
Glia; 2002 Dec; 40(3):300-11. PubMed ID: 12420310
[TBL] [Abstract][Full Text] [Related]
20. Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability.
Wang E; Dimova N; Sperle K; Huang Z; Lock L; McCulloch MC; Edgar JM; Hobson GM; Cambi F
Exp Neurol; 2008 Dec; 214(2):322-30. PubMed ID: 18835559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
